USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
European Blood Pathogen Inactivation Market
European Blood Pathogen Inactivation Market
RELEASE DATE
30-Jun-2010
30-Jun-2010
REGION
Europe
Europe
Research Code: M4A6-01-00-00-00
SKU: HC01828-EU-MR_06730
$4,950.00
In stock
SKU
HC01828-EU-MR_06730
Description
This study focuses on the blood pathogen inactivation market in Western Europe pertaining to the technologies that are currently in use and under development for pathogen inactivation of plasma, platelets and RBCs. Segment-wise revenue forecasting has been done for plasma and platelets. The market sizing and growth rates are pertaining to the seven key regions of Western Europe. The study also attempts to analyse the country-wise regulatory scenario for PR and PI technologies in Europe. General regulatory and market trends have also been discussed on a geographical basis. The study also analyses the challenges that influence this industry and the key market drivers and restraints.
Table of Contents
Overview of the Blood Pathogen Inactivation Market
- Market Overview of the European Blood Pathogen Reduction Market
Exchange Rates
- Exchange Rates for European Blood Pathogen Inactivation Market
Key Industry Challenges
- Identification of Key Challenges Facing the Industry
Introduction
- Emerging Pathogens
- Overview of Nucleic Acid Testing and Implementation
- Bacterial Screening
- Prion Detection and Removal
- An Introduction to Pathogen Inactivation
European Blood Pathogen Inactivation Market
- Market Overview
- Scope and Segmentation
- Research Methodology
- Market Engineering Measurements
- Market Drivers
- Market Restraints
- Revenue Forecasts
- Competitive Structure
Region-wise Regulatory and Technology Trends in Pathogen Inactivation
- Germany
- France
- The United Kingdom
- Spain
- Italy
- Benelux
- Scandinavia
Platelets
Plasma
Red Blood Cells
- Technology and Product Analysis
- Clinical Trials
- Revenue Forecasts
Strategic Recommendations
Key Industry Participants in the Market
Decision Support Databases for the Industry Participants
This study focuses on the blood pathogen inactivation market in Western Europe pertaining to the technologies that are currently in use and under development for pathogen inactivation of plasma, platelets and RBCs. Segment-wise revenue forecasting has been done for plasma and platelets. The market sizing and growth rates are pertaining to the seven key regions of Western Europe. The study also attempts to analyse the country-wise regulatory scenario for PR and PI technologies in Europe. General regulatory and market trends have also been discussed on a geographical basis. The study also analyses the challenges that influence this industry and the key market drivers and restraints.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | M4A6-01-00-00-00 |
| Is Prebook | No |